Our accreditations

Accredited by the most competent and prestigious industry bodies

Future Health Biobank is one of the world’s most accredited stem cell bank. Regarded by its peers as one of the most innovative, highly considered centre of excellence for quality and service within the stem cell banking industry. Processes in the UK laboratory and storage in Switzerland and the UK are licensed and accredited to the highest level and operate to GMP standards.

Future Health Biobank’s UK laboratory is a Human Tissue Bank, licensed by the Human Tissue Authority (HTA) and accredited by the Medicines and Healthcare Products Regulatory Agency (MHRA) of the UK Department of Health.

The UK Department of Health was amongst the first government bodies in Europe to issue a specific Code of Practice to govern the activities of Human Tissue Banks, which includes Cord Blood Stem Cell Banks. The objective of this Code of Practice is to ensure that safe, reliable quality tissue is produced and supplied to the health service for therapeutic purposes and medical applications. It is the Gold Standard for stem cell bank operations.

Request a brochure

  • This field is for validation purposes and should be left unchanged.

AABB - American Association of Blood Banks

Future Health Biobank received AABB (American Association of Blood Banks) accreditation in 2016, facility ID number 138834, committing to ensuring quality throughout all operations.

HTA - Human Tissue Authority

Future Health Biobank was licensed by the HTA in April 2006, receiving a full 3 year substantive licence on 1st September 2006, making the company the first cord blood bank to be licensed by the Human Tissue Authority (HTA). Formal licensing is only awarded following robust, lengthy and detailed audits of the company’s complete business and laboratory processes. Regular inspections ensure ongoing maintenance of the required standards to ensure continued licensing.

Future Health Biobank is regulated by the HTA and holds a licence (number 22503) granted under Regulation 7(1) and (2) and Schedule 2 of the HHuman Tissue (Quality and Safety for Human Application) Regulations 2007 (as amended) for (1) the procurement, testing, processing, distribution and/or import/export of tissues and/or cells intended for human application and (2) the storage of tissues and/or cells intended for human application.

ISO - International Standards Institute

Future Health Biobank is certified according to ISO 9001:2008, which ensures quality management systems provide the foundation to better customer satisfaction, staff motivation and continual improvement.
Future Health Biobank is certified (number FS554566) by BSI for operating a Quality Management System which complies with the requirement of ISO 9001:2008 for the scope of the procurement, storage, testing, processing, import and export, distribution and disposal of stem cells.

MHRA - Medicines and Healthcare products Regulatory Agency

Future Health Biobank is regulated by the MHRA and holds a Blood Establishment Authorisation (number BEA 21314) granted in accordance with the provisions of the Blood Safety and Quality Regulations 2005 No. 50 (as amended) to undertake the storage and distribution of blood and blood components.

OFSP - Federal Office of Public Health

Future Health Biobank SA Switzerland has received the Federal Office of Public Health’s licence for importation, exportation and storage of cord blood stem cells since December 2013.

GMP – Good Manufacturing Practice

Good Manufacturing Practice guidelines provide guidance for manufacturing, testing, and quality assurance in order to ensure that a drug product is safe for human use. In Switzerland, these regulations are in accordance with the Pharmaceutical Inspection Convention/Cooperation (PIC/S) and the Directives of the European Union. Future Health Biobank Switzerland has received the Certificate of GMP Compliance (autologous and allogenic use) since June 2013.


Swissmedic has delivered to Future Health Biobank SA Switzerland a licence for the import/export and long term cryopreservation of cord blood and cord tissue for autologous and allogeneic applications since 2013.

Why choose Future Health?

Once you’ve decided that Cord Blood Banking is for you, you then need to decide which biobank you’re going to trust with your baby’s sample. Here’s why we think you should choose us;

Accredited by the most competent and prestigious industry bodies

As one of the most accedited stem cell bank in the world, we offer HTA and MHRA approved stem cell banking services across over 75 countries.

Samples stored from all over the world; a trustfull storage in Switzerland

We have processed and stored more samples than all other UK banks combined, so you can be confident that your baby’s stem cells are stored by the UK’s most experienced bank.

We dispose two biobanks

We own and operate two operational centres over two separate geographical locations. Owning two biobanks means we are still able to store your baby’s stem cells in the event of a problem